185 related articles for article (PubMed ID: 38798123)
1. Effect of increasing doses of colchicine on the treatment of 333 COVID-19 inpatients.
Tiholov R; Lilov AI; Georgieva G; Palaveev KR; Tashkov K; Mitev V
Immun Inflamm Dis; 2024 May; 12(5):e1273. PubMed ID: 38798123
[TBL] [Abstract][Full Text] [Related]
2. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
Reis S; Metzendorf MI; Kuehn R; Popp M; Gagyor I; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015395. PubMed ID: 38032024
[TBL] [Abstract][Full Text] [Related]
3. Colchicine for the treatment of COVID-19.
Mikolajewska A; Fischer AL; Piechotta V; Mueller A; Metzendorf MI; Becker M; Dorando E; Pacheco RL; Martimbianco ALC; Riera R; Skoetz N; Stegemann M
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015045. PubMed ID: 34658014
[TBL] [Abstract][Full Text] [Related]
4. Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome.
Scarsi M; Piantoni S; Colombo E; Airó P; Richini D; Miclini M; Bertasi V; Bianchi M; Bottone D; Civelli P; Cotelli MS; Damiolini E; Galbassini G; Gatta D; Ghirardelli ML; Magri R; Malamani P; Mendeni M; Molinari S; Morotti A; Salada L; Turla M; Vender A; Tincani A; Brucato A; Franceschini F; Furloni R; Andreoli L
Ann Rheum Dis; 2020 Oct; 79(10):1286-1289. PubMed ID: 32732245
[TBL] [Abstract][Full Text] [Related]
5. Colchicine anti-inflammatory therapy for non-intensive care unit hospitalized COVID-19 patients: results from a pilot open-label, randomized controlled clinical trial.
Haroon MZ; Farooq U; Ashraf S; Zeb S; Gillani SY; Malik S; Ali R; Irshad R; Mehmood Z; Abbas Y; Masood A; Ghafoor A; Khalil AT; Asif H; Khan S; Ujjan ID; Nigar R; Livingstone S; Pascual-Figal DA; Togni S; Allergini P; Riva A; Khan A
J Physiol Pharmacol; 2022 Jun; 73(3):. PubMed ID: 36302537
[TBL] [Abstract][Full Text] [Related]
6. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.
Deftereos SG; Giannopoulos G; Vrachatis DA; Siasos GD; Giotaki SG; Gargalianos P; Metallidis S; Sianos G; Baltagiannis S; Panagopoulos P; Dolianitis K; Randou E; Syrigos K; Kotanidou A; Koulouris NG; Milionis H; Sipsas N; Gogos C; Tsoukalas G; Olympios CD; Tsagalou E; Migdalis I; Gerakari S; Angelidis C; Alexopoulos D; Davlouros P; Hahalis G; Kanonidis I; Katritsis D; Kolettis T; Manolis AS; Michalis L; Naka KK; Pyrgakis VN; Toutouzas KP; Triposkiadis F; Tsioufis K; Vavouranakis E; Martinèz-Dolz L; Reimers B; Stefanini GG; Cleman M; Goudevenos J; Tsiodras S; Tousoulis D; Iliodromitis E; Mehran R; Dangas G; Stefanadis C;
JAMA Netw Open; 2020 Jun; 3(6):e2013136. PubMed ID: 32579195
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of colchicine in patients with moderate COVID-19: A double-blinded, randomized, placebo-controlled trial.
Rahman M; Datta PK; Islam K; Haque M; Mahmud R; Mallik U; Hasan P; Haque M; Faruq I; Sharif M; Ratul RH; Azad KAK; Miah T; Rahman MM
PLoS One; 2022; 17(11):e0277790. PubMed ID: 36383611
[TBL] [Abstract][Full Text] [Related]
8. Can we still consider treatment with colchicine effective in SARS-COV-2 infection? Systematic review, meta-analysis, and trial sequential analysis.
De-Miguel-Balsa E; Estevan-Ortega R; Sempere-Selva MT; Latour-Pérez J; Baeza-Román A; Moya-Martinez A; Ramos-Rincon JM
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7151-7161. PubMed ID: 34859881
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Colchicine use in patients with COVID-19: A systematic review and meta-analysis.
Chiu L; Lo CH; Shen M; Chiu N; Aggarwal R; Lee J; Choi YG; Lam H; Prsic EH; Chow R; Shin HJ
PLoS One; 2021; 16(12):e0261358. PubMed ID: 34962939
[TBL] [Abstract][Full Text] [Related]
11. Effect of colchicine on mortality in patients with COVID-19 - A systematic review and meta-analysis.
Zein AFMZ; Raffaello WM
Diabetes Metab Syndr; 2022 Feb; 16(2):102395. PubMed ID: 35078098
[TBL] [Abstract][Full Text] [Related]
12. Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects.
Al-Kuraishy HM; Al-Gareeb AI; Qusty N; Cruz-Martins N; El-Saber Batiha G
Pulm Pharmacol Ther; 2021 Apr; 67():102008. PubMed ID: 33727066
[TBL] [Abstract][Full Text] [Related]
13. Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.
Bonaventura A; Vecchié A; Dagna L; Tangianu F; Abbate A; Dentali F
Inflamm Res; 2022 Mar; 71(3):293-307. PubMed ID: 35113170
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of patients with COVID-19 Pneumonia treated with corticosteroids and colchicine in Colombia.
Pinzón MA; Cardona Arango D; Betancur JF; Ortiz S; Holguín H; Arias Arias C; Muñoz Palacio BJ; Amarillo M; Llano JF; Montoya P
Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):66. PubMed ID: 34521428
[TBL] [Abstract][Full Text] [Related]
15. Colchicine use might be associated with lower mortality in COVID-19 patients: A meta-analysis.
Elshafei MN; El-Bardissy A; Khalil A; Danjuma M; Mubasher M; Abubeker IY; Mohamed MFH
Eur J Clin Invest; 2021 Sep; 51(9):e13645. PubMed ID: 34185313
[TBL] [Abstract][Full Text] [Related]
16. Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
Diaz R; Orlandini A; Castellana N; Caccavo A; Corral P; Corral G; Chacón C; Lamelas P; Botto F; Díaz ML; Domínguez JM; Pascual A; Rovito C; Galatte A; Scarafia F; Sued O; Gutierrez O; Jolly SS; Miró JM; Eikelboom J; Loeb M; Maggioni AP; Bhatt DL; Yusuf S;
JAMA Netw Open; 2021 Dec; 4(12):e2141328. PubMed ID: 34964849
[TBL] [Abstract][Full Text] [Related]
17. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
18. Oral Colchicine and Low-Dose Aspirin Combination Therapy for Non-elderly, Non-severe, Early Time From Onset, Adult Outpatients with Coronavirus Disease 2019 (COVID-19) during "The Fifth Pandemic Wave" in Japan.
Inokuchi T; Homma T; Kitasato Y; Akiyama M; Chikasue A; Nishii Y; Ban S; Adachi T; Sonezaki A; Masuda H; Kamei H; Takenaka M; Tanaka M; Okamoto M; Hoshino T;
Kurume Med J; 2024 Jul; 70(1.2):39-45. PubMed ID: 38508737
[TBL] [Abstract][Full Text] [Related]
19. Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study.
Manenti L; Maggiore U; Fiaccadori E; Meschi T; Antoni AD; Nouvenne A; Ticinesi A; Cerundolo N; Prati B; Delsante M; Gandoflini I; Donghi L; Gentile M; Farina MT; Oliva V; Zambrano C; Regolisti G; Palmisano A; Caminiti C; Cocchi E; Ferrari C; Riella LV; Cravedi P; Peruzzi L
PLoS One; 2021; 16(3):e0248276. PubMed ID: 33760858
[TBL] [Abstract][Full Text] [Related]
20. Complete, Rapid Resolution of Severe Bilateral Pneumonia and Acute Respiratory Distress Syndrome in a COVID-19 Patient: Role for a Unique Therapeutic Combination of Inhalations With Bromhexine, Higher Doses of Colchicine, and Hymecromone.
Mondeshki T; Bilyukov R; Tomov T; Mihaylov M; Mitev V
Cureus; 2022 Oct; 14(10):e30269. PubMed ID: 36381705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
